Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

Study Links Ovarian Cancer Survival To Low Levels of 2 Proteins

Posted by Chrissie Cole
Thursday, December 18, 2008 2:26 PM EST
Category: Major Medical
Tags: FDA and Prescription Drugs, Protecting Your Family, Women's Health, Ovarian Cancer

LEARN MORE

IMAGE SOURCE: © Wikimedia Commons / Ovarian Cancer Awareness / author: MesserWoland

New research suggests a woman’s likelihood of surviving ovarian cancer may be linked to two levels of two different proteins.

Women with high levels of both proteins had a median survival of 11 years compared with just over 2.6 years for those with low levels of both proteins, said study senior study author Dr. Anil K. Sood, a professor in gynecologic oncology and cancer biology at the University of Texas M.D. Anderson Cancer Center in Houston.

More specifically, low levels of a protein called Dicer predicted poorer outcomes, the researchers found.

The findings can help predict survival and may also guide the way for new treatments of the disease in the future.

Ovarian cancer is the deadliest of gynecologic cancers and the fifth leading cause of cancer among American women occurring in one of every 69 women. An estimated 20,000 American women will be diagnosed with the disease each year.

MicroRNA interference molecules help to regulate gene expression. Specifically, they can shut down genes and, as such, may represent a new avenue for treatment. MicroRNA regulates processes that are important for aspects of cell growth and that have provided insight in the mechanisms of human cancer.

The two enzymes highlighted in this study, Dicer (also named because it dices up RNA) and Drosha, are involved in two types of RNA interference.

Researchers analyzed the makeup of 111 ovarian cancer tumors, which were compared to patient’s clinical results. The outcome was supported by a separate analysis in a different group of 132 ovarian cancer patients.

Low levels of Dicer enzyme also predicted worse survival in breast and lung cancer patients; Drosha had less of an association in these cancers.

The study is published in the December 18 online issue of the New England Journal of Medicine. #


No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes